MediLife Logo Site (1).png

Commercial Consulting & Distribution

We specialise in market access & commercial strategy for MedTech product adoption and growth.

We provide end-to-end commercial, market access, and go-to-market support to help MedTech companies bring their products to the right healthcare audiences.

Our team works across strategy, pricing, reimbursement, and stakeholder engagement to ensure your innovation reaches adoption. With the UK as a strategic launchpad, we position your product for NHS access while laying the groundwork for wider international growth.

You bring the innovation. We bring the structure to support it.


How we work

  • Short-term packages or long-term partnerships

  • Milestone-based payments with transparent pricing

  • End-to-end project management

  • Evidence generation aligned to clinical practice and market access

What we offer

  • Ensure compliance to the correct UK governance

  • Evidence evaluation, review and market positioning

  • Health economics & business case development

  • KOL Engagement & Positioning

  • National Bodies Engagement

  • Dedicated sales & marketing resource

  • Tender monitoring & inclusion

  • Optimise the route to market, private & NHS

  • NHS procurement framework readiness

  • Dedicated sales & marketing resource

  • NHS Supply Chain management

  • KAM implementation

  • National Bodies Engagement

  • NHS procurement adoption

  • Private sector engagement

  • Digital lead generation

  • Strategic & operational marketing

  • Tender monitoring & inclusion

Take our Market Readiness Assessment

Not sure if your MedTech product is ready for the UK market? Complete our free Market Readiness Assessment to identify gaps in your commercial strategy, evidence generation, and market access plan.

Case Study

Rescuing an Underperfoming Clinical Trial

In 2023, MediLife was approached by one of our partners regarding a clinical trial that was struggling with recruitment, budget overruns, and operational inefficiencies.

This case study outlines how MediLife's intervention helped transform the study's performance.

27% increase in recruitment

Boost in Principal Investigator engagement

Increased commercial sales

  • “Working with MediLife was a very positive experience - they were always very helpful and on hand if matters arose, which is the most important thing from both a CI and PI perspective.”

    Chief Investigator

  • "MediLife has provided sage advice and followed up with timely and smart coordination to enable quick completion of objectives and action items relating to clinical study activities (site qualification, site contracting, site approvals, government approvals, site initiation)."

    US Custom Made Device Manufacturer

  • “We started working with Ian and his team at MediLife in 2019 and they have been instrumental in enabling us to successfully launch our products. They have supported us with many key areas of our business including initial development of our Global strategy, UK regulations, managing our clinical study, supply chain distribution & logistics as well as providing us with a sales team and Global marketeer to support our product launches. The MediLife team have also helped us to develop and improve our products based on valuable customer feedback they have captured. Suffice to say, we have built a strong partnership with MediLife, one which I hope to see continue for many years to come.”

    CEO, Swedish MedTech